Concepedia

Joseph R. Piccotti

JR

16

Publications

981

Citations

14

H-Index

1996

Active since

Affiliations

Pfizer (United States)(Current)

University of Michigan

University of Utah

Bristol-Myers Squibb (United States)

Amgen (United States)

Joseph R. Piccotti is an author at Pfizer (United States) specializing in medicine, cell biology, and immunology.

Top concepts

MedicineImmunologyCell BiologyImmunotherapyHealthCell DeathAutoimmunityInflammationCancer ResearchRadiation Oncology

Publications per year

1996–2024

16

Publications

16

Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma

Joshua D. Hansen, Matthew Correa, Mark A. Nagy et al. · Journal of Medicinal Chemistry · 2020 · 204 citations · Full text

Hematological Malignancy, Novel Therapy, Medicine +15

CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia

Joshua D. Hansen, Matthew Correa, Matt Alexander et al. · Journal of Medicinal Chemistry · 2021 · 138 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Cell Death +17

IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity

Joseph R. Piccotti, Stephanie Chan, Richard E. Goodman et al. · The Journal of Immunology · 1996 · 131 citations

Alloantigen-Reactive Th1 Development in IL-12-Deficient Mice

Joseph R. Piccotti, Kewang Li, Sherri Y. Chan et al. · The Journal of Immunology · 1998 · 109 citations · Full text

Inflammation, Cytokine, Autoimmune Disease +14

Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4+ and CD8+ IFN-γ-producing cells

Joseph R. Piccotti, Stephanie Chan, King C. Li et al. · The Journal of Immunology · 1997 · 108 citations · Full text

Rows per page

1–5 of 16